{"prompt": "['Trial ID: LP0162-1339', 'Date: 29-Aug-2018', 'Version: 4.0', 'Page 115 of 129', 'In order to perform their role effectively, CRAs and persons involved in quality assurance and', 'inspections will need direct access to source data, e.g. medical records, laboratory reports,', 'appointment books, etc. If the electronic medical record does not have a visible audit trail, the', 'investigator must provide the CRA with signed and dated printouts. In addition, relevant site', 'staff should be available for discussions at monitoring visits and between monitoring visits', '(e.g. by telephone).', 'Protocol compliance', 'Protocol deviations will be documented and notified to the investigator. LEO will assess all', 'protocol deviations and decide if any of these deviations must be reported to the regulatory', 'authorities as a serious breach of GCP and the protocol, as required by local legislation.', 'Protocol deviations will be included in the CTR', 'Sponsor audits, IRB/IEC review, and regulatory agency inspections', 'The clinical trial will be subject to audits conducted by LEO or inspections from domestic or', 'foreign regulatory authorities or from IRBs/IECs. Audits and inspections may take place', 'during or after the trial. The investigator and the site staff as well as LEO staff have an', 'obligation to cooperate and assist in audits and inspections. This includes giving auditors and', 'inspectors direct access to all source documents and other documents at the trial site relevant', 'to the clinical trial. This includes permission to examine, verify and reproduce any records', 'and reports that are important to the evaluation of the trial.', 'If the trial site is contacted for an inspection by competent authorities, LEO must be notified', 'immediately.', 'Data handling', 'Subject data should be entered into the eCRF as soon as possible after each visit in', 'accordance with the requirements described in the Clinical Trial Agreement, if applicable.', 'Queries for discrepant data will be generated automatically by the system upon entry or', \"manually by the CRA, sponsor's medical expert, or the data manager. All queries will be\", 'raised electronically within the electronic data capture system. This systematic validation will', 'ensure that a clean and consistent database is provided for the statistical analysis.', 'An electronic PRO (ePRO) solution will be used to capture patient-reported data (data from', 'questionnaires completed at the trial site and eDiary data). By the use of an ePRO, data will', 'be available immediately after data entry and available for monitors and site personnel,', 'including the investigator, with read access only. The ePRO system is a separate application', 'from the eCRF and data captured from the eCRF and the ePRO will be stored on different', 'TMF-000005673 - Version 4.0']['Trial ID: LP0162-1339', 'Date: 29-Aug-2018', 'Version: 4.0', 'Page 116 of 129', 'servers during data capture. Data from both systems will be included in the final trial', 'database.', 'External data transfers from vendors to LEO will be transmitted and handled via a secure file', 'transfer protocol site. Transmissions of electronic data from external data providers and of', 'ePRO data to the clinical database are illustrated in Panel 12.', 'Panel 12 Transmission of electronic data', 'Who', 'What', 'Where', 'Investigator/site', 'Assessments', 'entered into', 'eCRF database', 'eCRF', 'Subject', 'Questionnaires', 'filled in using', 'ePRO database', 'ePRO/Diary', 'Laboratory', 'Clinical', 'CTR', 'Laboratory', 'database', 'analysis', 'Lab database', 'ECG vendor', 'ECG analysis', 'ECG database', 'CMO', 'Weighing of', 'TCS', 'CMO database', 'Abbreviations: CMO, contract manufacturing organisation; CTR, clinical trial report; ECG, electrocardiogram;', 'eCRF, electronic case report form; ePRO, electronic patient-reported outcome; Lab, laboratory; TCS, topical', 'corticosteroid.', 'Archiving of trial documentation', 'The investigator at each trial site must make arrangements to store the essential trial', 'documents including the Investigator Trial File (ICH E6, Guideline for Good Clinical', 'Practice) until LEO informs the investigator that the documents are no longer to be retained or', 'longer if required by local regulations.', 'In addition, the investigator is responsible for the archiving of all relevant source documents', 'so that the trial data can be compared against source data after the completion of the trial (for', 'example in case of an inspection from regulatory authorities).', 'TMF-000005673 - Version 4.0']\n\n###\n\n", "completion": "END"}